[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 1979

Urinary MHPG Levels and Tricyclic Antidepressant Drug SelectionA Preliminary Communication on Improved Drug Selection in Clinical Practice

Author Affiliations

From the Schools of Behavioural Sciences (Dr Cobbin and Ms Requin-Blow) and Chemistry (Dr L. Williams), Macquarie University, North Ryde, NSW, Australia, and The Northside Clinic (Dr W. Williams), Greenwich, NSW, Australia.

Arch Gen Psychiatry. 1979;36(10):1111-1115. doi:10.1001/archpsyc.1979.01780100081007

• The 24-hour urinary 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) output was used as the basis for selection of tricyclic antidepressant drug therapy for the depressed patient population treated by one psychiatrist over a period of ten months in a psychiatric clinic. Use of MHPG output level as the criterion for drug selection resulted in significantly better clinical results than had been obtained previously by the same psychiatrist using more traditional selection methods on a similar depressed patient population. A correlation was noted between patients' pretreatment MHPG output levels and three symptoms of depression (guilt, agitation, and diurnal variation) as measured on the Hamilton Rating Scale for Depression.